The Study on the Diagnosis and Efficacy of Multimodal Sleep for Chronic Insomnia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050114

Enrollment

Unknown

Registered

2021-08-16

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia

Interventions

Experimental group:Multimodal sleep

control group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Comply with ICSD-3 diagnostic criteria for insomnia, with long-term sleep initiation or/and maintenance difficulties; 2. Insomnia for more than 3 months and >= 3 times a week; 3. PSQI >= 8 points; 4. Aged >= 18 years; 5. The patient voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, liver, and kidney diseases (chronic respiratory failure, heart failure, nephritis, liver cirrhosis, etc.); 2. Infectious diseases and parasitic diseases (viral hepatitis, tuberculosis, liver echinococcosis, etc.) ); 3. Severe neuropsychiatric diseases (Alzheimer's, schizophrenia, bipolar disorder, etc.); 4. Cachexia, severe malnutrition, and autoimmune system diseases; 5. Malignant tumors (liver cancer, leukemia, thyroid cancer, etc.); 6. Pregnant women and lactating patients.

Design outcomes

Primary

Measure	Time frame
Polysomnography;	—

Countries

China

Contacts

Public ContactAn Jianxiong

Aviation General Hospital of China Medical University

anjianxiong@yeah.net+86 13801281750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026